Life sciences organisations face numerous challenges and hurdles on their growth path from start-up to scale-up and beyond. In a series of half-day events, we will discuss in-depth challenges and opportunities that define and influence the road to success of life sciences organisations.
In the first of this series of Deep Dive Events, we will develop ‘Partnering opportunities for biotech across the life cycle’.
Questions such as: ‘What is my business model? Who do I partner with? How do I legally structure a partnership? What is the impact of partnerships on the valuation of my company? How should I build my organisation to achieve the benefits of a partnership? How to ensure quality and compliance along partnerships?
These are typical strategic questions a young life sciences company will regularly face as it evolves from start-up to scale-up. Attending this half-day event, you will hear from experts and experienced entrepreneurs about the different aspects of bringing in partners as part of your strategies for growing your company.
by Pascale Engelen, co-General Manager, flanders.bio
by Rupert Dixon, Senior Director, Strategic Drug Development & Peter Thomas, Principal, Consulting Services, IQVIA
by Paul Soons, Early Development Expert, Janssen Pharmaceutica
by Koen De Witte, CEO, reMYND
by Leen van Goethem, Senior Managing Associate & Pierre Queritet, Director, PwC Legal
by KBC Securities (more details will follow)
by Chris De Jonghe, PMV
by David Decouche, Manager Consultancy & Outplacement, Select HR
by Dominiek Rossillion, Competence Center Manager, QbD
by Caroline Sage, Senior Project Manager, Modis
Eventhal Den Berg
Bergkapelstraat 98, 1840 Londerzeel
flanders.bio members: 40,- EUR
non-flanders.bio members: 80,- EUR
Organised with the support of these flanders.bio's strategic partners: